Who
Brendan Hannah
Cbo, COO & Cco
Company insider
Files Form 4 as: Cbo, COO & Cco, Quince Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 4
- Sells
- 0
- Bought
- $112K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 May 2022
- Last trade
- 23 Jan 2026
- Last filed
- 23 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jan 2026filed 23 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —365,000 at $0.00 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —365,000 at $0.00 | filing |
| 5 Dec 2025filed 8 Dec 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,271 at $0.00 | filing |
| 5 Dec 2025filed 8 Dec 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,280 at $0.00 | filing |
| 5 Dec 2025filed 8 Dec 2025 | Quince TherapeuticsBiotechnology | SEC FORM 4 Code M | $1,2492,271 at $0.55 | filing |
| 5 Dec 2025filed 8 Dec 2025 | Quince TherapeuticsBiotechnology | SEC FORM 4 Code M | $24K25,280 at $0.94 | filing |
| 18 Jun 2025filed 23 Jun 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $4,90637,736 at $0.13 | filing |
| 18 Jun 2025filed 23 Jun 2025 | Quince TherapeuticsBiotechnology | SEC FORM 4 Code A | $45K37,736 at $1.20 | filing |
| 28 Jan 2025filed 11 Feb 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 21 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,3912,280 at $0.61 | filing |
| 21 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $3,1005,000 at $0.62 | filing |
| 21 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $15K23,565 at $0.63 | filing |
| 20 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,5252,500 at $0.61 | filing |
| 20 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $2,0543,424 at $0.60 | filing |
| 19 Aug 2024filed 21 Aug 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,2502,155 at $0.58 | filing |
| 4 Jun 2024filed 5 Jun 2024 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —56,061 at $0.00 | filing |
| 4 Jun 2024filed 5 Jun 2024 | Quince TherapeuticsBiotechnology | SEC FORM 4 Code M | $31K56,061 at $0.55 | filing |
| 1 Feb 2024filed 2 Feb 2024 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 24 Oct 2023filed 26 Oct 2023 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 8 Aug 2023filed 9 Aug 2023 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $88K71,762 at $1.22 | filing |
News
No headline names them, or the companies they trade most, lately.